rTMS-enhanced Psychotherapy for Borderline Personality Disorder

Launched by MASARYKOVA UNIVERZITA · Feb 5, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring a new treatment approach for women with borderline personality disorder (BPD) by combining a type of talk therapy called Dialectical Behavioral Therapy (DBT) with a technique known as repetitive transcranial magnetic stimulation (rTMS). DBT helps people learn skills to manage their emotions and improve relationships, while rTMS uses magnetic fields to stimulate specific areas of the brain. The goal of this study is to see if this combination can help improve symptoms and create lasting positive changes for those affected by BPD.

To participate in the trial, women aged 16 and older who have been diagnosed with borderline personality disorder according to specific guidelines can apply. However, individuals with certain conditions, such as neurological disorders or severe mental illnesses, will not be eligible. Participants can expect to receive both DBT and rTMS treatments during the study and will be closely monitored throughout the process. This research is currently recruiting, and it's an opportunity for eligible individuals to potentially benefit from an innovative approach to managing their condition.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • diagnosis of borderline personality disorder according to Diagnostic and Statistical Manual 5th Edition (DSM-5) criteria (rated by Structured Clinical Interview for DSM-5 for Personality Disorders, BPD section)
• • minimum age 16, informed consent of the patient
• • informed consent of patient's legal representative in case of patients under age 18
• Exclusion Criteria:
• • neurological disorder
• • comorbid affective disorder or schizophrenia-related disorder
• • intelligence quotient\<70
• • contraindications for MRI measurement
• • contraindication for rTMS treatment
• • pregnancy